Aug 12 (Reuters) - Revance Therapeutics Inc ( RVNC ):
* CROWN LABORATORIES AND REVANCE ANNOUNCE ENTRY INTO MERGER
AGREEMENT
* CROWN TO ACQUIRE REVANCE FOR $6.66 PER SHARE IN CASH
* PROPOSED DEAL FOR TOTAL ENTERPRISE VALUE OF $924 MILLION
* AFTER DEAL, CO'S STOCK WILL NO LONGER BE PUBLICLY TRADED
ON
NASDAQ
Source text for Eikon:
Further company coverage: